Skip to main content

Delays to HPV screening cost £3 million and miss 48 cervical cancer cases every month

A one-year delay in introducing human papillomavirus (HPV) testing as the main test in cervical screening would miss the opportunity to prevent 581 cases of cervical cancer in England at an estimated value of £32 million in lost quality of life, according to a study by researchers at Queen Mary University of London and King’s College London.

Published on:
Back to top